Cytotoxicity Tests for Evaluating Medical Devices: An Alert for the Development of Biotechnology Health Products
Open Access
- 1 January 2017
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Journal of Biomedical Science and Engineering
- Vol. 10 (09), 431-443
- https://doi.org/10.4236/jbise.2017.109033
Abstract
The risks and damages related to the use of products, technologies and services of sanitary interest can be due to defects or manufacturing failures. Certain products already contain a certain degree of risk, which requires strict quality control in their production, distribution and use, as well as in the disposal of their waste in the environment. With continuous development in science and technology, medical devices must undergo intradermal irritation and testing for sensitization, cytotoxicity, and acute systemic toxicity. In health care, biotechnology aims to provide technology-based products or processes related to energy, food, and health, which are capable of stimulating new businesses, expanding exports, integrating the value chain and stimulating new demands for innovative products and processes, taking into account health policies. The present article was prepared by a bibliographical survey of the electronic databases PubMed, Lilacs, and Bireme. Cell culture testing can be successfully employed, as it is reproducible, rapid, sensitive, and financially accessible for performing in vitro toxicity testing. Thus, it has been possible to optimize the development phase of new products by decreasing animal use or even replacing them in certain tests. Some in vitro assays validated by the Organization for Economic Cooperation and Development in the area of health products have already replaced animal testing.Keywords
This publication has 16 references indexed in Scilit:
- Real‐time cellular analysis as a novel approach for in vitro cytotoxicity testing of medical device extractsJournal of Biomedical Materials Research Part A, 2013
- Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical ApplicationsChemical Reviews, 2012
- Poly(2‐ethyl‐2‐oxazoline) as Alternative for the Stealth Polymer Poly(ethylene glycol): Comparison of in vitro Cytotoxicity and HemocompatibilityMacromolecular Bioscience, 2012
- Regulation of Medical Devices in the United States and European UnionThe New England Journal of Medicine, 2012
- Polímeros usados como sistemas de transporte de princípios ativosPolímeros, 2011
- A multiparametric assay to compare the cytotoxicity of endodontic sealers with primary human osteoblastsInternational Endodontic Journal, 2011
- A novel in vitro model for preclinical testing of the hemocompatibility of intravascular stents according to ISO 10993-4Journal of Materials Science: Materials in Medicine, 2011
- Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibilityJournal of Materials Chemistry, 2011
- Cuidados paliativos: interfaces, conflitos e necessidadesCiencia & Saude Coletiva, 2008
- Tissue Culture Method for Screening Toxicity of Plastic Materials to be Used in Medical PracticeJournal of Pharmaceutical Sciences, 1965